HonCode

Go Back   HER2 Support Group Forums > Articles of Interest
Register Gallery FAQ Members List Calendar Today's Posts

Reply
 
Thread Tools Display Modes
Old 06-03-2006, 09:48 AM   #1
AlaskaAngel
Senior Member
 
AlaskaAngel's Avatar
 
Join Date: Sep 2005
Location: Alaska
Posts: 2,018
Question for the HER2support crew at ASCO

Could you find out if there any presentation or report or information discussing whether raloxifene has demonstrated the same resistance problems that tamoxifen has, now that raloxifene has shown its effectiveness?

Because tamoxifen has such a long history and has been the drug of choice for premenopausal HR+ patients, it still seems to be accepted as the only option -- but does this make any sense in terms of HR+ HER2's?

AlaskaAngel
AlaskaAngel is offline   Reply With Quote
Old 06-03-2006, 01:36 PM   #2
heblaj01
Senior Member
 
Join Date: Apr 2006
Posts: 543
If I may,I would like to add an other question to that of AlaskaAngel for those attending ASCO:

any clinical trial results comparing Herceptin alone versus Herceptin+aromatase inhibitor? (or failing that, any comment from experts on the pros & cons of the combo)

Last edited by heblaj01; 06-03-2006 at 01:39 PM.. Reason: Added comments
heblaj01 is offline   Reply With Quote
Old 06-03-2006, 02:49 PM   #3
R.B.
Senior Member
 
Join Date: Mar 2006
Posts: 1,843
Herceptin is reported to block FAS activity.


Does Herceptin block manifacture of longer chain fats.

Omega 3 including DHA and EPA

Omega six incudng Arachnidonic acid

In breast only.

In whole body.

In whole body except brain.
R.B. is offline   Reply With Quote
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On

Forum Jump


All times are GMT -7. The time now is 11:34 PM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter